Latest News & Updates
Breaking News
19 hours ago
Simantini Singh Deo
Other trending news you may like to read
Novartis Wins FDA Approval For Pluvicto In Earlier Stage Metastatic Prostate Cancer, Expanding Patient Access
Novartis wins FDA approval for Pluvicto in earlier-stage metastatic hormone-sensitive prostate cancer, nearly doubling eligible patients.
Simantini Singh Deo
XORTX Therapeutics Appoints Financial Services Veteran Depesh Narotam As Independent Director
XORTX Therapeutics appoints Depesh Narotam, a 20-year financial services veteran, as an independent director to its Board.
Simantini Singh Deo
Rose Hill Life Sciences Appoints Biopharma Veteran Jama Pitman As CEO To Lead Psilocybin Therapy Development
Rose Hill Life Sciences names Jama Pitman, a 25-year biopharma veteran, as CEO to lead its psilocybin-based clinical programs.
Simantini Singh Deo
Profusa Signs Option Agreement To Acquire G3 Vision Labs And Build Public Diagnostics Business With $111 Million Revenue Base
Profusa signs an Option Agreement to acquire G3 Vision Labs, aiming to build a public diagnostics business on a $111 million revenue base.
Simantini Singh Deo
